Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael E Cox

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Frontiers in Pharmacology|March 30, 2018
East Indian Sandalwood Oil Is a Phosphodiesterase Inhibitor: A New Therapeutic Option in the Treatment of Inflammatory Skin DiseaseManju Sharma, Corey Levenson, John C Browning, et al.
Journal of Biochemical and Molecular Toxicology|December 29, 2015
The Flame-Retardant Tris(1,3-dichloro-2-propyl) Phosphate Represses Androgen Signaling in Human Prostate Cancer Cell LinesAlexandra R Reers, Margaret L Eng, Tony D Williams, et al.
Chemico-Biological Interactions|February 17, 2015
p,p'-Dichlorodiphenyltrichloroethane (p,p'-DDT) and p,p'-dichlorodiphenyldichloroethylene (p,p'-DDE) repress prostate specific antigen levels in human prostate cancer cell linesLilian I L Wong, Mark P Labrecque, Naokazu Ibuki, et al.
Oncotarget|April 22, 2017
Alternative RNA splicing of the MEAF6 gene facilitates neuroendocrine prostate cancer progressionAhn R Lee, Yinan Li, Ning Xie, et al.
Cell Cycle (Georgetown, Tex.)|July 16, 2015
Integrin-linked kinase regulates senescence in an Rb-dependent manner in cancer cell linesRose Duminuco, Jake W Noble, Joseph Goody, et al.
Molecular Cancer Therapeutics|October 1, 2014
The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancerNaokazu Ibuki, Mazyar Ghaffari, Hadas Reuveni, et al.
Biomicrofluidics|March 15, 2019
Development of a microfluidic platform for size-based hydrodynamic enrichment and PSMA-targeted immunomagnetic isolation of circulating tumour cells in prostate cancerHadi Esmaeilsabzali, Robert T M Payer, Yubin Guo, et al.
The Journal of Biological Chemistry|August 11, 2007
Raft-dependent endocytosis of autocrine motility factor is phosphatidylinositol 3-kinase-dependent in breast carcinoma cellsLiliana D Kojic, Bharat Joshi, Patrick Lajoie, et al.
The Prostate|October 1, 2009
Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancerJunya Furukawa, Christopher J Wraight, Susan M Freier, et al.
International Journal of Cancer|April 9, 2013
TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signalingNaokazu Ibuki, Mazyar Ghaffari, Mitali Pandey, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Frontiers in Pharmacology|March 30, 2018
East Indian Sandalwood Oil Is a Phosphodiesterase Inhibitor: A New Therapeutic Option in the Treatment of Inflammatory Skin DiseaseManju Sharma, Corey Levenson, John C Browning, et al.
Journal of Biochemical and Molecular Toxicology|December 29, 2015
The Flame-Retardant Tris(1,3-dichloro-2-propyl) Phosphate Represses Androgen Signaling in Human Prostate Cancer Cell LinesAlexandra R Reers, Margaret L Eng, Tony D Williams, et al.
Chemico-Biological Interactions|February 17, 2015
p,p'-Dichlorodiphenyltrichloroethane (p,p'-DDT) and p,p'-dichlorodiphenyldichloroethylene (p,p'-DDE) repress prostate specific antigen levels in human prostate cancer cell linesLilian I L Wong, Mark P Labrecque, Naokazu Ibuki, et al.
Oncotarget|April 22, 2017
Alternative RNA splicing of the MEAF6 gene facilitates neuroendocrine prostate cancer progressionAhn R Lee, Yinan Li, Ning Xie, et al.
Cell Cycle (Georgetown, Tex.)|July 16, 2015
Integrin-linked kinase regulates senescence in an Rb-dependent manner in cancer cell linesRose Duminuco, Jake W Noble, Joseph Goody, et al.
Molecular Cancer Therapeutics|October 1, 2014
The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancerNaokazu Ibuki, Mazyar Ghaffari, Hadas Reuveni, et al.
Biomicrofluidics|March 15, 2019
Development of a microfluidic platform for size-based hydrodynamic enrichment and PSMA-targeted immunomagnetic isolation of circulating tumour cells in prostate cancerHadi Esmaeilsabzali, Robert T M Payer, Yubin Guo, et al.
The Journal of Biological Chemistry|August 11, 2007
Raft-dependent endocytosis of autocrine motility factor is phosphatidylinositol 3-kinase-dependent in breast carcinoma cellsLiliana D Kojic, Bharat Joshi, Patrick Lajoie, et al.
The Prostate|October 1, 2009
Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancerJunya Furukawa, Christopher J Wraight, Susan M Freier, et al.
International Journal of Cancer|April 9, 2013
TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signalingNaokazu Ibuki, Mazyar Ghaffari, Mitali Pandey, et al.
Pageof 7